Medical Professionals

Cooperatively tackling debilitating diseases

We work in collaboration with a supportive network of medical professionals from leading academic institutions in both the United States and Europe in order to advance our products and tailor our therapeutic approaches to specific clinical needs. By working closely with these Key Opinion Leaders (KOLs), we feel that we can reach our common goal of rapidly bringing state-of-the-art topical gene therapies into the clinic, thus providing new hope to patients suffering from dermatological diseases in which we believe there are currently no known effective treatments.

Please contact us at [email protected] for more information about our clinical trials or visit our ClinicalTrials.gov listing at the link below.

Please review our Expanded Access policy at the link below. For physicians seeking pre-approval access to one of our investigational drugs, please contact us at [email protected].